Target intelligence / Profile preview

Glutamate [NMDA] Receptor (NMDAR)

Target
NMDAR
Molecular classification
Ion channel, Ligand-gated ion channel, Glutamate receptor, Ionotropic glutamate receptor
01

Overview

The glutamate [NMDA] receptor, commonly referred to as the NMDA receptor (NMDAR), is a subtype of ionotropic glutamate receptors that play a central role in excitatory neurotransmission in the mammalian brain. It is named for its selective activation by N-methyl-D-aspartate (NMDA), a synthetic agonist. The NMDA receptor is crucial for synaptic plasticity, learning, and memory formation and has been implicated in both physiological processes and pathological conditions such as excitotoxicity. The functional NMDA receptor is typically an obligate heterotetramer composed of two glycine-binding GluN1 subunits and two glutamate-binding GluN2 subunits arranged alternately (GluN1–GluN2–GluN1–GluN2). Channel opening requires simultaneous binding of glycine and glutamate along with membrane depolarization to relieve Mg²⁺ block within the channel pore. Once activated, NMDARs allow Ca²⁺ influx along with Na⁺ entry and K⁺ efflux—this high calcium permeability distinguishes them from other iGluRs. Alterations or mutations affecting NMDA receptors are linked to several neurological disorders including epilepsy, schizophrenia, intellectual disability syndromes like anti-NMDA-receptor encephalitis. Excessive activation contributes directly to neuronal injury during ischemic events such as stroke due to calcium overload-induced cell death pathways.

Other names
NMDA receptorN-methyl-D-aspartate receptorGluN receptor
02

Mechanism of action

Channel opening requires simultaneous binding of glycine and glutamate along with membrane depolarization to relieve Mg²⁺ block within the channel pore. Once activated, NMDARs allow Ca²⁺ influx along with Na⁺ entry and K⁺ efflux.

03

Biological functions

Synaptic transmissionSynaptic plasticityLong-term potentiation (LTP)Long-term depression (LTD)Neural developmentCircuit formationLearningMemory consolidationExcitatory neurotransmission
04

Disease associations

EpilepsySchizophreniaIntellectual disabilityAnti-NMDA-receptor encephalitisStrokeNeurodegenerative diseasesExcitotoxicity
05

Safety considerations

ExcitotoxicityNeuronal death due to calcium overloadSide effects of NMDAR antagonists (e.g., cognitive impairment)
06

Interacting drugs

NMDA

5 more in the full profile.

Beyond the preview

Go deeper on Glutamate [NMDA] Receptor (NMDAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate [NMDA] Receptor (NMDAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call